Zai Lab Appoints Scott Morrison to its Board of Directors

NEXT STORY
Ultragenyx Initiates Cyprus2+, a Pivotal Clinical Trial Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
PREV STORY
First Patients Treated in Southern Europe with Stereotaxis Genesis Robotic Technology
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Longitudinal Study Finds One Medical’s Member-Based & Technology-Powered Primary Care Model Delivers Outsized Impact in Controlling Diabetes

author_avatar
NASDAQ Market News

ERYTECH fornisce un aggiornamento sullo studio di fase 2 sponsorizzato dallo sperimentatore di Eryaspase per il trattamento di seconda linea della leucemia linfoblastica acuta

author_avatar
NASDAQ Market News

vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes

author_avatar
NASDAQ Market News